- Open Access
Erratum to: Impact of medication adherence on renal function in comorbid patients with type 2 diabetes and depression: protocol for a cohort study
© The Author(s). 2017
- Published: 10 May 2017
The original article was published in BMC Family Practice 2015 16:124
The authors of this study protocol  would like to amend it and clarify that one of the medication adherence scales, the Morisky Medication Adherence Scale 8 (MMAS-8) [2–4], will not be used. This amendment will not cause any changes to the substantive contents of the article since the medication adherence will be assessed by the use of other measures. The Institutional Review Board of the National Center of Neurology and Psychiatry approved this change to the study protocol.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Ito H, Sato T, Satoh-Asahara N, Noda M. Impact of medication adherence on renal function in comorbid patients with type 2 diabetes and depression: protocol for a cohort study. BMC Fam Pract. 2015;16:124. doi:10.1186/s12875-015-0339-1.View ArticlePubMedPubMed CentralGoogle Scholar
- Morisky DE, Ang A, Krousel-Wood M, Ward H. Predictive validity of a medication adherence measure for hypertension control. J Clin Hypertens. 2008;10(5):348–54.View ArticleGoogle Scholar
- Krousel-Wood MA, Islam T, Webber LS, Morisky DE, Muntner P. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Managed Care. 2009;15(1):59–66.Google Scholar
- Morisky DE, DiMatteo MR. Improving the measurement of self-reported medication nonadherence: final response. J Clin Epidemio. 2011;64:258–63.View ArticleGoogle Scholar